![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug ...
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Aethlon Medical Announces Data Against Metastatic Melanoma | cancerfr | Melanoma | 0 | 09-10-2010 03:47 AM |
| Tasigna receives approval for chronic myeloid leukemia in Canada | cancerfr | Leukemia | 0 | 08-21-2010 02:37 AM |
| Accuray's CyberKnife G4 System Receives Shonin Approval | cancerfr | Extracranial Germ Cell Tumor | 0 | 08-04-2010 06:54 AM |
| Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteo | cancerfr | Pituitary Tumor | 0 | 06-11-2010 06:28 PM |
| Aethlon Medical plans to initiate patient recruitment for cancer immunotherapy study | cancerfr | Vaginal Cancer | 0 | 05-04-2010 02:41 PM |